2015 Mar 09
Keeping your hair in chemo
The Weill Cornell Breast Center and Tessa Cigler, M.D., are highlighted for their use of the innovative cold cap treatment to prevent hair loss during chemotherapy. Read more
2015 Mar 09
Researchers sequence genome of Classical Hodgkin's lymphoma cells
A team of researchers led by Ethel Cesarman has sequenced the genome of Classical Hodgkin lymphoma, illuminating exactly which proteins are altered in individual patients. Read more
2015 Mar 09
A Different Prescription: Seeking Progress in Women’s Cancers
Meyer Cancer Center director Lewis Cantley discusses progress and treatments for women's cancers. Read more
2015 Mar 05
DNA safeguard may be key in cancer treatment
Ithaca members Marcus Smolka and Haiyuan Yu have developed a new technique to understand the actions of key proteins required for cancer cells to proliferate. Read more
2015 Mar 05
Nobel Laureate Harold Varmus joins Meyer Cancer Center
Harold Varmus, director of the National Cancer Institute (NCI) and co-winner of the Nobel Prize, will join Weill Cornell Medical College as the Lewis Thomas University Professor of Medicine, effective April 1 Read more
2015 Mar 04
Meyer Cancer Center welcomes renowned radiation oncologist Silvia Formenti
Silvia C. Formenti, M.D., will join the Meyer Cancer Center as Associate Director of Radiation Oncology. Read more
2015 Mar 03
Most commonly used treatment for prostate cancer is radiotherapy
New Meyer Cancer Center member Jim C. Hu analyzes treatment options for prostate cancer in this JAMA Oncology study. Read more
2015 Mar 02
Tackling tumors with both brain and brawn
The Meyer Cancer Center’s new associate director of translational research, Howard Fine, will be founding director of a new Brain Tumor Center. Read more
2015 Mar 02
Weill research highlighted at #GU15 conference
The research of several Meyer Cancer Center members was highlighted at the recent ASCO Genitourinary Cancers Symposium Read more
2015 Mar 02
Bartlett family honors Dr. Manish Shah
A $1 million gift from the family of the late Robert Bartlett, D.M.D.,will establish the Bartlett Family Associate Professorship in Gastrointestinal Oncology. Read more
2015 Feb 19
Fighting the War on Cancer
To really stand a chance against cancer, we should focus on more interdisciplinary collaboration, writes biomedical engineer Claudia Fischbach in this guest piece. Read more
2015 Feb 19
Communication networks discovered between tumors and surrounding microenvironment
A research team led by Vivek Mittal has identified complex communication networks between tumors and surrounding blood vessels, immune cells, connective tissue cells and structural cells. Read more
2015 Feb 18
Role of Transplantation in High-Risk CLL
Richard Furman, M.D., talks to OncLive about the role of allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia. Read more
2015 Feb 13
The Treatment Challenges of Neuroendocrine Prostate Cancer
Himisha Beltran, M.D., presented at the Chemotherapy Foundation Symposium about neuroendocrine prostate cancer, a high-risk, lethal subset of disease. Read more
2015 Feb 09
Mantle Cell Lymphoma Treatment Challenges
Associate professor Jia Ruan, M.D., Ph.D., talks to OncLive about initial treatment methods for mantle cell lymphoma (MCL). Read more
2015 Feb 09
Entrepreneurship in Action
Several Meyer Cancer Center members have been featured in the latest issue of Weill Cornell Medicine magazine. Read more
2015 Feb 07
Optimizing Treatment With Ibrutinib in High-Risk CLL
Richard Furman, M.D., director of Weill's CLL Research Center, participates in a panel discussion about therapy for patients with chronic lymphocytic leukemia (CLL) whose tumors harbor a 17p deletion. Read more
2015 Feb 05
Big Data and Bacteria: Mapping the New York Subway’s DNA
Pathologist Christopher Mason and his research team gathered DNA from turnstiles, ticket kiosks, railings and benches in a transit system shared by 5.5 million riders every day. Read more
2015 Feb 04
Onartuzumab for Gastroesophageal Adenocarcinoma
Manish A Shah, M.D., director of gastrointestinal oncology, discusses a recent phase II study of FOLFOX with or without onartuzumab, a MET inhibitor, for the treatment of metastatic gastroesophageal adenocarcinoma. Read more
2015 Feb 03
Researchers enthusiastic over Obama's new $215m precision medicine initiative
Mark Rubin, director of Weill Cornell's Institute for Precision Medicine, recently traveled to the White House as President Barack Obama unveiled a new $215m precision medicine initiative. Read more
